«

»

FDA Rejects Oleandrin, Extract Pushed By MyPillow CEO, As A Dietary Supplement

The agency concluded that Oleandrin cannot “reasonably be expected to be safe.”

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive